Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 3016 AL 3030

Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task

Sacrey LA, Travis SG, Whishaw IQ.

Behav Brain Res. 2011 Mar 1;217(2):391-8. doi: 10.1016/j.bbr.2010.11.010. Epub 2010 Nov 10.

Stem cell integrins: implications for ex-vivo culture and cellular therapies

Prowse AB, Chong F, Gray PP, Munro TP.

Stem Cell Res. 2011 Jan;6(1):1-12. doi: 10.1016/j.scr.2010.09.005. Epub 2010 Oct 7.

Role of astrocytes in brain function and disease

Sidoryk-Wegrzynowicz M, Wegrzynowicz M, Lee E, Bowman AB, Aschner M.

Toxicol Pathol. 2011 Jan;39(1):115-23. doi: 10.1177/0192623310385254. Epub 2010 Nov 12.

The effects of verbal instructions on gait in people with Parkinson's disease: a systematic review of randomized and non-randomized trials

Fok P, Farrell M, McMeeken J, Kuo YL.

Clin Rehabil. 2011 May;25(5):396-407. doi: 10.1177/0269215510387648. Epub 2010 Nov 15.

Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease

Thompson AW, Liu H, Hays RD, Katon WJ, Rausch R, Diaz N, Jacob EL, Vassar SD, Vickrey BG.

Parkinsonism Relat Disord. 2011 Jan;17(1):40-5. doi: 10.1016/j.parkreldis.2010.10.007. Epub 2010 Nov 17.

Oseltamivir-induced dyskinesia in Parkinson's disease

Kadowaki T, Komagamine T, Suzuki K, Hirata K.

Parkinsonism Relat Disord. 2011 Feb;17(2):133-4. doi: 10.1016/j.parkreldis.2010.10.013. Epub 2010 Nov 16.

Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease

Ondo WG, Hunter C, Isaacson SH, Silver DE, Stewart RM, Tetrud JW, Davidson A.

Parkinsonism Relat Disord. 2011 Feb;17(2):117-8. doi: 10.1016/j.parkreldis.2010.10.001. Epub 2010 Nov 16.

Nonlinear speech analysis algorithms mapped to a standard metric achieve clinically useful quantification of average Parkinson's disease symptom severity

Tsanas A, Little MA, McSharry PE, Ramig LO.

J R Soc Interface. 2011 Jun 6;8(59):842-55. doi: 10.1098/rsif.2010.0456. Epub 2010 Nov 17.

The role of otx2 in adult mesencephalic-diencephalic dopaminergic neurons

Simeone A, Di Salvio M, Di Giovannantonio LG, Acampora D, Omodei D, Tomasetti C.

Mol Neurobiol. 2011 Apr;43(2):107-13. doi: 10.1007/s12035-010-8148-y. Epub 2010 Nov 18.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in parkinsonian patients

Ceravolo R, Brusa L, Galati S, Volterrani D, Peppe A, Siciliano G, Pierantozzi M, Moschella V, Bonuccelli U, Stanzione P, Stefani A.

Eur J Neurol. 2011 Jun;18(6):842-9. doi: 10.1111/j.1468-1331.2010.03254.x. Epub 2010 Nov 19.

Boxing training for patients with Parkinson disease: a case series

Combs SA, Diehl MD, Staples WH, Conn L, Davis K, Lewis N, Schaneman K.

Phys Ther. 2011 Jan;91(1):132-42. doi: 10.2522/ptj.20100142. Epub 2010 Nov 18.

Measuring participation in individuals with Parkinson disease: relationships with disease severity, quality of life, and mobility

Duncan RP, Earhart GM.

Disabil Rehabil. 2011;33(15-16):1440-6. doi: 10.3109/09638288.2010.533245. Epub 2010 Nov 20.

Rapidly progressive dementias and the treatment of human prion diseases

Appleby BS, Lyketsos CG.

Expert Opin Pharmacother. 2011 Jan;12(1):1-12. doi: 10.1517/14656566.2010.514903. Epub 2010 Nov 23.

Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease

Ohno Y.

CNS Neurosci Ther. 2011 Feb;17(1):58-65. doi: 10.1111/j.1755-5949.2010.00211.x. Epub 2010 Nov 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias